P

Inventor

WANG DAQING

US56 patents
⚠️ This page may combine multiple inventors who share the name “WANG DAQING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IDERA PHARMACEUTICALS INC

23 patents
US7569554B2Aug 4, 2009

Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents

IDERA PHARMACEUTICALS INC23 citations93
US9453228B2Sep 27, 2016

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

IDERA PHARMACEUTICALS INC21 citations92
US8361986B2Jan 29, 2013

Synthetic agonists of TLR9

IDERA PHARMACEUTICALS INC18 citations92
US7960362B2Jun 14, 2011

Synthetic agonists of TLR9

IDERA PHARMACEUTICALS INC19 citations92
US10463686B2Nov 5, 2019

Immune modulation with TLR9 agonists for cancer treatment

IDERA PHARMACEUTICALS INC6 citations84
US9260719B2Feb 16, 2016

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

IDERA PHARMACEUTICALS INC8 citations84
US9206430B2Dec 8, 2015

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

IDERA PHARMACEUTICALS INC7 citations84
US9096858B2Aug 4, 2015

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

IDERA PHARMACEUTICALS INC8 citations84
US8383598B2Feb 26, 2013

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

IDERA PHARMACEUTICALS INC12 citations84
US8377898B2Feb 19, 2013

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

IDERA PHARMACEUTICALS INC15 citations84
US8357665B2Jan 22, 2013

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

IDERA PHARMACEUTICALS INC10 citations84
US7884197B2Feb 8, 2011

Synthetic agonists of TLR9

IDERA PHARMACEUTICALS INC13 citations84
US7875594B2Jan 25, 2011

Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents

IDERA PHARMACEUTICALS INC11 citations84
US9243050B2Jan 26, 2016

Stabilized immune modulatory RNA (SIMRA) compounds for TLR7 and TLR8

IDERA PHARMACEUTICALS INC7 citations83
US10835550B2Nov 17, 2020

Immune modulation with TLR9 agonists for cancer treatment

IDERA PHARMACEUTICALS INC1 citations73
US10772907B2Sep 15, 2020

Immune modulation with TLR9 agonists for cancer treatment

IDERA PHARMACEUTICALS INC1 citations73
US9540651B2Jan 10, 2017

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

IDERA PHARMACEUTICALS INC2 citations73
US8362233B2Jan 29, 2013

Stabilized immune modulatory RNA (SIMRA) compounds

IDERA PHARMACEUTICALS INC5 citations73
US9828601B2Nov 28, 2017

Compositions for inhibiting checkpoint gene expression and uses thereof

IDERA PHARMACEUTICALS INC3 citations69
US11224611B2Jan 18, 2022

Immune modulation with TLR9 agonists for cancer treatment

IDERA PHARMACEUTICALS INC0 citations62
US10066230B2Sep 4, 2018

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

IDERA PHARMACEUTICALS INC0 citations52
US10041076B2Aug 7, 2018

Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response

IDERA PHARMACEUTICALS INC0 citations52
US9688993B2Jun 27, 2017

Toll-like receptor 9 antagonist and methods of use thereof

IDERA PHARMACEUTICALS INC1 citations51

FRANKLINWH ENERGY STORAGE INC

8 patents

KANDIMALLA EKAMBAR

6 patents

DEUTSCH MICHAEL

4 patents

KANDIMALLA EKAMBAR R

3 patents

TERADIODE INC

2 patents

AGRAWAL SUDHIR

1 patent

LAN TAO

1 patent

FRANKLINWH TECH CO LTD

1 patent

SYNERK INC

1 patent

Showing the top 50 of 56 patents by PatentIndex Score.